GROWTH HORMONE DEFICIENCY, PEDIATRIC
Clinical trials for GROWTH HORMONE DEFICIENCY, PEDIATRIC explained in plain language.
Never miss a new study
Get alerted when new GROWTH HORMONE DEFICIENCY, PEDIATRIC trials appear
Sign up with your email to follow new studies for GROWTH HORMONE DEFICIENCY, PEDIATRIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Weekly shot could replace daily growth hormone injections for children
Disease control CompletedThis phase 3 trial tests a long-acting growth hormone called TransCon hGH, given as a once-weekly injection, in about 150 children with growth hormone deficiency. The study aims to see if the weekly shot is safe and helps children grow at a normal rate. All participants receive t…
Matched conditions: GROWTH HORMONE DEFICIENCY, PEDIATRIC
Phase: PHASE3 • Sponsor: Ascendis Pharma Endocrinology Division A/S • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
Weekly shot could replace daily needles for kids with growth hormone deficiency
Disease control CompletedThis phase 3 trial tests whether a once-weekly injection of TransCon hGH works as well as daily growth hormone injections in prepubertal children with growth hormone deficiency. About 150 children who have not received growth hormone treatment before will receive either the weekl…
Matched conditions: GROWTH HORMONE DEFICIENCY, PEDIATRIC
Phase: PHASE3 • Sponsor: Ascendis Pharma Endocrinology Division A/S • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
Weekly shot could replace daily needles for kids with growth hormone deficiency
Disease control CompletedThis study tests a long-acting growth hormone called TransCon hGH, given as a once-weekly injection, in children with growth hormone deficiency who have already completed a prior TransCon trial. The goal is to see if the weekly shot remains safe and effective over the long term. …
Matched conditions: GROWTH HORMONE DEFICIENCY, PEDIATRIC
Phase: PHASE3 • Sponsor: Ascendis Pharma A/S • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC